0001493152-24-024753.txt : 20240621
0001493152-24-024753.hdr.sgml : 20240621
20240621163027
ACCESSION NUMBER: 0001493152-24-024753
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240618
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shekhat Denil Nanji
CENTRAL INDEX KEY: 0002016605
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41765
FILM NUMBER: 241060897
MAIL ADDRESS:
STREET 1: MIRA PHARMACEUTICALS, INC.
STREET 2: 1200 BRICKELL AVENUE, SUITE 1950 #1183
CITY: MIAMI
STATE: FL
ZIP: 33131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001904286
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 853354547
STATE OF INCORPORATION: FL
BUSINESS ADDRESS:
STREET 1: 1200 BRICKELL AVENUE
STREET 2: SUITE 1950 #1183
CITY: MIAMI
STATE: FL
ZIP: 33131
BUSINESS PHONE: 813-369-5150
MAIL ADDRESS:
STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
FORMER COMPANY:
FORMER CONFORMED NAME: Mira1a Therapeutics, Inc.
DATE OF NAME CHANGE: 20220112
4
1
ownership.xml
X0508
4
2024-06-18
0
0001904286
MIRA PHARMACEUTICALS, INC.
MIRA
0002016605
Shekhat Denil Nanji
C/O MIRA PHARMACEUTICALS, INC.
1200 BRICKELL AVE. SUITE 1950 #1183
MIAMI
FL
33131
1
0
0
0
0
Nonqualified Stock Option (right to buy)
0.71
2024-06-18
4
A
0
50000
0
A
2034-06-18
Common Stock
50000
41666
D
The exercise price of the stock options issued to the Reporting Person is equal to the Nasdaq Official Closing Price of the Issuer's common stock on June 18, 2024, the date of the grant.
The stock options were issued to the Reporting Person on June 18, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"), and in accordance with the terms of a consulting agreement dated June 18, 2024, by and between the Reporting Person and MIRA Pharmaceuticals, Inc. The stock options will vest in three equal tranches, with the first tranche vesting immediately on the grant date of June 18, 2024, the second tranche vesting on December 18, 2024, and the final tranche vesting on June 18, 2025.
Represents (i) 25,000 stock options that were issued to the Reporting person on March 25, 2024, that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $1.16 each and (ii) 16,666 stock options that were issued to the Reporting Person on June 18, 2024, that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.71 each.
/s/ Denil Shekhat
2024-06-21